These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 32116064

  • 1. Treatment patterns for biologics in ulcerative colitis and Crohn's disease: a Danish Nationwide Register Study from 2003 to 2015.
    Alulis S, Vadstrup K, Borsi A, Nielsen A, Rikke Jørgensen T, Qvist N, Munkholm P.
    Scand J Gastroenterol; 2020 Mar; 55(3):265-271. PubMed ID: 32116064
    [Abstract] [Full Text] [Related]

  • 2. Drug utilization of biologic therapy in Crohn's disease and ulcerative colitis: a population-based Danish cohort study 2015-2020.
    Jensen KJ, Jensen CB, Wennerström C, Burisch J, Petersen J.
    Scand J Gastroenterol; 2023 Jul; 58(7):726-736. PubMed ID: 36802972
    [Abstract] [Full Text] [Related]

  • 3. Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Jung YS, Han M, Park S, Cheon JH.
    Dig Dis Sci; 2020 May; 65(5):1436-1444. PubMed ID: 31677070
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The cost burden of Crohn's disease and ulcerative colitis depending on biologic treatment status - a Danish register-based study.
    Alulis S, Vadstrup K, Olsen J, Jørgensen TR, Qvist N, Munkholm P, Borsi A.
    BMC Health Serv Res; 2021 Aug 18; 21(1):836. PubMed ID: 34407821
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies.
    Dulai PS, Osterman MT, Lasch K, Cao C, Riaz F, Sandborn WJ.
    Dig Dis Sci; 2019 Sep 18; 64(9):2478-2488. PubMed ID: 30923985
    [Abstract] [Full Text] [Related]

  • 10. First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study.
    Anisdahl K, Svatun Lirhus S, Medhus AW, Moum B, Melberg HO, Høivik ML.
    Scand J Gastroenterol; 2021 Oct 18; 56(10):1163-1168. PubMed ID: 34320885
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network.
    Romeo AC, Ventimiglia M, Dipasquale V, Orlando A, Citrano M, Pellegrino S, Accomando S, Cottone M, Romano C.
    Clin Res Hepatol Gastroenterol; 2020 Apr 18; 44(2):223-229. PubMed ID: 31204314
    [Abstract] [Full Text] [Related]

  • 12. Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource.
    Kapizioni C, Desoki R, Lam D, Balendran K, Al-Sulais E, Subramanian S, Rimmer JE, De La Revilla Negro J, Pavey H, Pele L, Brooks J, Moran GW, Irving PM, Limdi JK, Lamb CA, UK IBD BioResource Investigators , Parkes M, Raine T.
    J Crohns Colitis; 2024 Jun 03; 18(6):790-800. PubMed ID: 38041850
    [Abstract] [Full Text] [Related]

  • 13. Treatment Patterns and Sequencing in Patients With Inflammatory Bowel Disease.
    Brady JE, Stott-Miller M, Mu G, Perera S.
    Clin Ther; 2018 Sep 03; 40(9):1509-1521.e5. PubMed ID: 30126706
    [Abstract] [Full Text] [Related]

  • 14. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy.
    Dovizio M, Hartz S, Buzzoni C, Redondo I, Nedeljkovic Protic M, Birra D, Perrone V, Veronesi C, Degli Esposti L, Armuzzi A.
    Adv Ther; 2024 Jun 03; 41(6):2282-2298. PubMed ID: 38619721
    [Abstract] [Full Text] [Related]

  • 15. Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Almario CV, Keller MS, Chen M, Lasch K, Ursos L, Shklovskaya J, Melmed GY, Spiegel BMR.
    Am J Gastroenterol; 2018 Jan 03; 113(1):58-71. PubMed ID: 29206816
    [Abstract] [Full Text] [Related]

  • 16. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
    Korzenik J, Larsen MD, Nielsen J, Kjeldsen J, Nørgård BM.
    Aliment Pharmacol Ther; 2019 Aug 03; 50(3):289-294. PubMed ID: 31267570
    [Abstract] [Full Text] [Related]

  • 17. The incidence of Crohn's disease and ulcerative colitis since 1995 in Danish children and adolescents <17 years - based on nationwide registry data.
    Larsen MD, Baldal ME, Nielsen RG, Nielsen J, Lund K, Nørgård BM.
    Scand J Gastroenterol; 2016 Sep 03; 51(9):1100-5. PubMed ID: 27160395
    [Abstract] [Full Text] [Related]

  • 18. Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs.
    Bossa F, Carparelli S, Latiano A, Palmieri O, Tavano F, Panza A, Pastore M, Marseglia A, D'Altilia M, Latiano T, Corritore G, Martino G, Nardella M, Guerra M, Terracciano F, Sacco M, Perri F, Andriulli A.
    Dig Liver Dis; 2021 Mar 03; 53(3):277-282. PubMed ID: 33423942
    [Abstract] [Full Text] [Related]

  • 19. Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort.
    Kaplan JL, Liu C, King EC, Bass JA, Patel AS, Tung J, Chen S, Lissoos T, Candela N, Saeed S, Colletti RB, for the ImproveCareNow Network .
    J Pediatr Gastroenterol Nutr; 2023 May 01; 76(5):566-575. PubMed ID: 36804501
    [Abstract] [Full Text] [Related]

  • 20. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases.
    Han M, Jung YS, Cheon JH, Park S.
    J Gastroenterol Hepatol; 2019 Jul 01; 34(7):1166-1174. PubMed ID: 30672608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.